Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1996 Jul;33(7):550–558. doi: 10.1136/jmg.33.7.550

Accurate diagnosis of carriers of deletions and duplications in Duchenne/Becker muscular dystrophy by fluorescent dosage analysis.

S C Yau 1, M Bobrow 1, C G Mathew 1, S J Abbs 1
PMCID: PMC1050661  PMID: 8818939

Abstract

We have developed a semiautomated approach to amplify 25 exons of the dystrophin gene using two fluorescent multiplex PCR assays which detect over 98% of reported deletions and 90% of duplications causing Duchenne/Becker muscular dystrophy. The 5' multiplex detects 11 exons from the proximal deletion hotspot of the gene while the 3' multiplex detects 14 exons from the central deletion hotspot. The PCR products are accurately sized and quantified by a fluorescent DNA sequencer after only 18 cycles of amplification. The amount of product amplified from each exon in a multiplex is divided by that from each of the other exons, and this ratio is compared with those from control samples to obtain a series of dosage quotients (DQ), from which the copy number of each exon is determined. No overlap was observed between the DQ values obtained from single and double copy loci. The assays can be used to screen both affected males and at risk female relatives for a mutation. The method has been evaluated as a female carrier test by conducting a blind trial on 150 coded samples. Sixty-three deletion carriers, two duplication carriers, and 84 normal female controls were all correctly identified, showing that carrier diagnosis is possible even in families where the nature of the mutation is unknown. Additionally the analysis showed a non-pathogenic duplication involving the muscle specific promoter and exon 1. Together these two multiplex assays detect over 70% of all mutations in the dystrophin gene, greatly simplifying and partly automating molecular diagnosis in Duchenne and Becker muscular dystrophy.

Full text

PDF
550

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbs S., Bobrow M. Analysis of quantitative PCR for the diagnosis of deletion and duplication carriers in the dystrophin gene. J Med Genet. 1992 Mar;29(3):191–196. doi: 10.1136/jmg.29.3.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Abbs S., Bobrow M. Report on the 16th ENMC workshop--carrier diagnosis of Duchenne and Becker muscular dystrophy. Neuromuscul Disord. 1993 May;3(3):241–242. doi: 10.1016/0960-8966(93)90066-s. [DOI] [PubMed] [Google Scholar]
  3. Abbs S., Yau S. C., Clark S., Mathew C. G., Bobrow M. A convenient multiplex PCR system for the detection of dystrophin gene deletions: a comparative analysis with cDNA hybridisation shows mistypings by both methods. J Med Genet. 1991 May;28(5):304–311. doi: 10.1136/jmg.28.5.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Beggs A. H., Koenig M., Boyce F. M., Kunkel L. M. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990 Nov;86(1):45–48. doi: 10.1007/BF00205170. [DOI] [PubMed] [Google Scholar]
  5. Beutler E., Gelbart T., Kuhl W. Interference of heparin with the polymerase chain reaction. Biotechniques. 1990 Aug;9(2):166–166. [PubMed] [Google Scholar]
  6. Blonden L. A., den Dunnen J. T., van Paassen H. M., Wapenaar M. C., Grootscholten P. M., Ginjaar H. B., Bakker E., Pearson P. L., van Ommen G. J. High resolution deletion breakpoint mapping in the DMD gene by whole cosmid hybridization. Nucleic Acids Res. 1989 Jul 25;17(14):5611–5621. doi: 10.1093/nar/17.14.5611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Chamberlain J. S., Gibbs R. A., Ranier J. E., Nguyen P. N., Caskey C. T. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988 Dec 9;16(23):11141–11156. doi: 10.1093/nar/16.23.11141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chance P. F., Fischbeck K. H. Molecular genetics of Charcot-Marie-Tooth disease and related neuropathies. Hum Mol Genet. 1994;3(Spec No):1503–1507. doi: 10.1093/hmg/3.suppl_1.1503. [DOI] [PubMed] [Google Scholar]
  9. Clemens P. R., Fenwick R. G., Chamberlain J. S., Gibbs R. A., de Andrade M., Chakraborty R., Caskey C. T. Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy families, using dinucleotide repeat polymorphisms. Am J Hum Genet. 1991 Nov;49(5):951–960. [PMC free article] [PubMed] [Google Scholar]
  10. Coffey A. J., Roberts R. G., Green E. D., Cole C. G., Butler R., Anand R., Giannelli F., Bentley D. R. Construction of a 2.6-Mb contig in yeast artificial chromosomes spanning the human dystrophin gene using an STS-based approach. Genomics. 1992 Mar;12(3):474–484. doi: 10.1016/0888-7543(92)90437-w. [DOI] [PubMed] [Google Scholar]
  11. Den Dunnen J. T., Grootscholten P. M., Bakker E., Blonden L. A., Ginjaar H. B., Wapenaar M. C., van Paassen H. M., van Broeckhoven C., Pearson P. L., van Ommen G. J. Topography of the Duchenne muscular dystrophy (DMD) gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet. 1989 Dec;45(6):835–847. [PMC free article] [PubMed] [Google Scholar]
  12. Feener C. A., Boyce F. M., Kunkel L. M. Rapid detection of CA polymorphisms in cloned DNA: application to the 5' region of the dystrophin gene. Am J Hum Genet. 1991 Mar;48(3):621–627. [PMC free article] [PubMed] [Google Scholar]
  13. Fujimura F. K., Northrup H., Beaudet A. L., O'Brien W. E. Genotyping errors with the polymerase chain reaction. N Engl J Med. 1990 Jan 4;322(1):61–61. doi: 10.1056/NEJM199001043220117. [DOI] [PubMed] [Google Scholar]
  14. Hodgson S., Hart K., Abbs S., Heckmatt J., Rodillo E., Bobrow M., Dubowitz V. Correlation of clinical and deletion data in Duchenne and Becker muscular dystrophy. J Med Genet. 1989 Nov;26(11):682–693. doi: 10.1136/jmg.26.11.682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hofker M. H., Skraastad M. I., Bergen A. A., Wapenaar M. C., Bakker E., Millington-Ward A., van Ommen G. J., Pearson P. L. The X chromosome shows less genetic variation at restriction sites than the autosomes. Am J Hum Genet. 1986 Oct;39(4):438–451. [PMC free article] [PubMed] [Google Scholar]
  16. Hu X. Y., Ray P. N., Murphy E. G., Thompson M. W., Worton R. G. Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet. 1990 Apr;46(4):682–695. [PMC free article] [PubMed] [Google Scholar]
  17. Kilimann M. W., Pizzuti A., Grompe M., Caskey C. T. Point mutations and polymorphisms in the human dystrophin gene identified in genomic DNA sequences amplified by multiplex PCR. Hum Genet. 1992 May;89(3):253–258. doi: 10.1007/BF00220535. [DOI] [PubMed] [Google Scholar]
  18. Koenig M., Beggs A. H., Moyer M., Scherpf S., Heindrich K., Bettecken T., Meng G., Müller C. R., Lindlöf M., Kaariainen H. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet. 1989 Oct;45(4):498–506. [PMC free article] [PubMed] [Google Scholar]
  19. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  20. Malhotra S. B., Hart K. A., Klamut H. J., Thomas N. S., Bodrug S. E., Burghes A. H., Bobrow M., Harper P. S., Thompson M. W., Ray P. N. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science. 1988 Nov 4;242(4879):755–759. doi: 10.1126/science.3055295. [DOI] [PubMed] [Google Scholar]
  21. Mansfield E. S., Blasband A., Kronick M. N., Wrabetz L., Kaplan P., Rappaport E., Sartore M., Parrella T., Surrey S., Fortina P. Fluorescent approaches to diagnosis of Lesch-Nyhan syndrome and quantitative analysis of carrier status. Mol Cell Probes. 1993 Aug;7(4):311–324. doi: 10.1006/mcpr.1993.1045. [DOI] [PubMed] [Google Scholar]
  22. Mansfield E. S., Robertson J. M., Lebo R. V., Lucero M. Y., Mayrand P. E., Rappaport E., Parrella T., Sartore M., Surrey S., Fortina P. Duchenne/Becker muscular dystrophy carrier detection using quantitative PCR and fluorescence-based strategies. Am J Med Genet. 1993 Dec 15;48(4):200–208. doi: 10.1002/ajmg.1320480406. [DOI] [PubMed] [Google Scholar]
  23. Mao Y. P., Cremer M. Detection of Duchenne muscular dystrophy carriers by dosage analysis using the DMD cDNA clone 8. Hum Genet. 1989 Jan;81(2):193–195. doi: 10.1007/BF00293903. [DOI] [PubMed] [Google Scholar]
  24. Mayrand P. E., Robertson J., Ziegle J., Hoff L. B., McBride L. J., Chamberlain J. S., Kronick M. N. Automated genetic analysis. Ann Biol Clin (Paris) 1991;49(4):224–230. [PubMed] [Google Scholar]
  25. Monaco A. P., Bertelson C. J., Liechti-Gallati S., Moser H., Kunkel L. M. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988 Jan;2(1):90–95. doi: 10.1016/0888-7543(88)90113-9. [DOI] [PubMed] [Google Scholar]
  26. Müllenbach R., Lagoda P. J., Welter C. An efficient salt-chloroform extraction of DNA from blood and tissues. Trends Genet. 1989 Dec;5(12):391–391. [PubMed] [Google Scholar]
  27. Prior T. W., Papp A. C., Snyder P. J., Highsmith W. E., Jr, Friedman K. J., Perry T. R., Silverman L. M., Mendell J. R. Determination of carrier status in Duchenne and Becker muscular dystrophies by quantitative polymerase chain reaction and allele-specific oligonucleotides. Clin Chem. 1990 Dec;36(12):2113–2117. [PubMed] [Google Scholar]
  28. Ried T., Mahler V., Vogt P., Blonden L., van Ommen G. J., Cremer T., Cremer M. Direct carrier detection by in situ suppression hybridization with cosmid clones of the Duchenne/Becker muscular dystrophy locus. Hum Genet. 1990 Oct;85(6):581–586. doi: 10.1007/BF00193578. [DOI] [PubMed] [Google Scholar]
  29. Roberts R. G., Barby T. F., Manners E., Bobrow M., Bentley D. R. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991 Aug;49(2):298–310. [PMC free article] [PubMed] [Google Scholar]
  30. Roberts R. G., Bentley D. R., Barby T. F., Manners E., Bobrow M. Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA. Lancet. 1990 Dec 22;336(8730):1523–1526. doi: 10.1016/0140-6736(90)93305-9. [DOI] [PubMed] [Google Scholar]
  31. Roberts R. G., Coffey A. J., Bobrow M., Bentley D. R. Determination of the exon structure of the distal portion of the dystrophin gene by vectorette PCR. Genomics. 1992 Aug;13(4):942–950. doi: 10.1016/0888-7543(92)90005-d. [DOI] [PubMed] [Google Scholar]
  32. Roberts R. G., Cole C. G., Hart K. A., Bobrow M., Bentley D. R. Rapid carrier and prenatal diagnosis of Duchenne and Becker muscular dystrophy. Nucleic Acids Res. 1989 Jan 25;17(2):811–811. doi: 10.1093/nar/17.2.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schwartz L. S., Tarleton J., Popovich B., Seltzer W. K., Hoffman E. P. Fluorescent multiplex linkage analysis and carrier detection for Duchenne/Becker muscular dystrophy. Am J Hum Genet. 1992 Oct;51(4):721–729. [PMC free article] [PubMed] [Google Scholar]
  34. Shapiro L. J., Yen P., Pomerantz D., Martin E., Rolewic L., Mohandas T. Molecular studies of deletions at the human steroid sulfatase locus. Proc Natl Acad Sci U S A. 1989 Nov;86(21):8477–8481. doi: 10.1073/pnas.86.21.8477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. den Dunnen J. T., Bakker E., Breteler E. G., Pearson P. L., van Ommen G. J. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature. 1987 Oct 15;329(6140):640–642. doi: 10.1038/329640a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES